Mainz Biomed N.V. (BST: 4TO)
Germany
· Delayed Price · Currency is EUR
6.64
-0.10 (-1.48%)
At close: Dec 5, 2024
Mainz Biomed Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 0.98 | 7.07 | 17.14 | 8.73 | 0.12 | - |
Cash & Short-Term Investments | 0.98 | 7.07 | 17.14 | 8.73 | 0.12 | - |
Cash Growth | -91.04% | -58.75% | 96.41% | 7020.57% | - | - |
Accounts Receivable | 0.14 | 0.09 | 0.06 | 0.02 | 0.04 | - |
Other Receivables | 0.2 | 0.26 | 0.2 | 0.09 | 0 | - |
Receivables | 0.34 | 0.35 | 0.26 | 0.11 | 0.04 | - |
Inventory | 0.52 | 0.61 | 0.18 | - | - | - |
Prepaid Expenses | 0.42 | 0.81 | 0.68 | 0.76 | 0.02 | - |
Other Current Assets | 0.13 | 0.14 | 0.12 | 0.01 | 0 | - |
Total Current Assets | 2.39 | 8.98 | 18.38 | 9.61 | 0.19 | - |
Property, Plant & Equipment | 2.86 | 3.03 | 1.84 | 0.43 | 0.49 | - |
Other Intangible Assets | 3.21 | 3.39 | - | - | - | - |
Other Long-Term Assets | - | 0 | 0.02 | - | - | - |
Total Assets | 8.45 | 15.41 | 20.24 | 10.04 | 0.67 | - |
Accounts Payable | 1.65 | 2.33 | 1.33 | 0.75 | 0.25 | - |
Accrued Expenses | 1.68 | 1.16 | 1.38 | 0.27 | 0.18 | - |
Short-Term Debt | - | - | - | 0.12 | 0.13 | - |
Current Portion of Long-Term Debt | 5.92 | 4.94 | 1.04 | 0.08 | 0.09 | - |
Current Portion of Leases | 0.32 | 0.29 | 0.29 | 0.06 | 0.05 | - |
Current Unearned Revenue | 0.12 | 0.14 | 0.2 | - | - | - |
Other Current Liabilities | 0.32 | 0.39 | - | 0.08 | 0 | - |
Total Current Liabilities | 10.01 | 9.24 | 4.24 | 1.35 | 0.7 | - |
Long-Term Debt | 0.98 | 1.03 | 0.94 | 1.94 | 2.27 | - |
Long-Term Leases | 1.05 | 1.17 | 0.96 | 0.39 | 0.45 | - |
Other Long-Term Liabilities | 0.55 | 0.73 | - | - | - | - |
Total Liabilities | 12.59 | 12.16 | 6.14 | 3.68 | 3.41 | - |
Common Stock | 0.28 | 0.24 | 0.16 | 0.14 | 0.06 | - |
Additional Paid-In Capital | 54.14 | 51.51 | 38.83 | 13.13 | 0.04 | - |
Retained Earnings | -80.35 | -69.33 | -43.03 | -16.64 | -4.95 | - |
Comprehensive Income & Other | 21.8 | 20.83 | 18.13 | 9.74 | 2.11 | - |
Shareholders' Equity | -4.14 | 3.25 | 14.1 | 6.36 | -2.74 | - |
Total Liabilities & Equity | 8.45 | 15.41 | 20.24 | 10.04 | 0.67 | - |
Total Debt | 8.27 | 7.42 | 3.23 | 2.58 | 2.98 | - |
Net Cash (Debt) | -7.29 | -0.35 | 13.91 | 6.15 | -2.86 | - |
Net Cash Growth | - | - | 126.19% | - | - | - |
Net Cash Per Share | -14.57 | -0.86 | 39.31 | 34.12 | -20.38 | - |
Filing Date Shares Outstanding | 0.64 | 0.55 | 0.37 | 0.35 | 0.14 | 0.14 |
Total Common Shares Outstanding | 0.64 | 0.53 | 0.37 | 0.3 | 0.14 | 0.14 |
Working Capital | -7.62 | -0.26 | 14.14 | 8.26 | -0.52 | - |
Book Value Per Share | -6.47 | 6.14 | 38.54 | 21.19 | -19.56 | - |
Tangible Book Value | -7.34 | -0.15 | 14.1 | 6.36 | -2.74 | - |
Tangible Book Value Per Share | -11.48 | -0.27 | 38.54 | 21.19 | -19.56 | - |
Machinery | 1.94 | 1.91 | 0.76 | 0.09 | 0.08 | - |
Construction In Progress | 0.05 | 0.06 | - | - | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.